Richard M. Bayney, Ph.D.
Vice President, Decision Analysis and Portfolio, Management, PRD
Johnson & Johnson
Balu Balasubramanian, Ph.D.,
Executive Director, Research and Development, Bristol-Myers Squibb Co.
Matt Bell, Ph.D., MA
Senior Director, Discovery Research Strategy, Wyeth
Dennis Engers
International Director, Preclinical Planning and Resource Management, sanofi-aventis
Rainer Fuchs, Ph.D.
Co-Head Discovery Research
Vice President, Research Informatics,
Biogen Idec Inc.
Richard Heaslip, Ph.D.
Vice President, Project and Portfolio Management,
Wyeth
Shama Kajiji, Ph.D., MBA
Director, Portfolio Franchise Management
Department,
Merck and Co
Sundeep Lal, Ph.D., MBA
Senior Director, New Products Licensing, Global
Human Health,
Merck & Co.
Michael Liebman, Ph.D.
Chief Scientific Officer,
Windber Research Institute
Jann Nielsen, Ph.D.
Director, Project Management,
Wyeth Research
James Resch, Ph.D.
Director, Strategic Planning, Global Discovery Affairs,
AstraZeneca
Jill Robinson, R.Ph., MBA
Vice President, Global Safety Surveillance & Epidemiology, Wyeth
Kim Slocum
Director, Strategic Planning & Business Development,
AstraZeneca LP
Sean Zhao, Ph.D.
Director, Pharmacovigilance and Global Safety, Amgen Inc.